Biotech Equipment Leasing vs Buying Cost-Benefit Analysis
WildExplorer5 Biotech startups face a $127k/year dilemma: lease cutting-edge ASME-Approved lab gear or drain capital buying FDA/UL-certified equipment outright. With 72% of labs overspending on outdated asset strategies (EPA Tested Industry…